These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 28094817)

  • 1. Immune dysfunction and neuroinflammation in autism spectrum disorder.
    Bjorklund G; Saad K; Chirumbolo S; Kern JK; Geier DA; Geier MR; Urbina MA
    Acta Neurobiol Exp (Wars); 2016; 76(4):257-268. PubMed ID: 28094817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study of high-dose intravenous immunoglobulin 5% for autism: Impact on autism spectrum and markers of neuroinflammation.
    Melamed IR; Heffron M; Testori A; Lipe K
    Autism Res; 2018 Mar; 11(3):421-433. PubMed ID: 29427532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune aberrations in children with Autism Spectrum Disorder: a case-control study from a tertiary care neuropsychiatric hospital in India.
    Basheer S; Venkataswamy MM; Christopher R; Van Amelsvoort T; Srinath S; Girimaji SC; Ravi V
    Psychoneuroendocrinology; 2018 Aug; 94():162-167. PubMed ID: 29804052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired lipid metabolism markers to assess the risk of neuroinflammation in autism spectrum disorder.
    Qasem H; Al-Ayadhi L; Bjørklund G; Chirumbolo S; El-Ansary A
    Metab Brain Dis; 2018 Aug; 33(4):1141-1153. PubMed ID: 29569150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune dysregulation in autism spectrum disorder.
    Hsiao EY
    Int Rev Neurobiol; 2013; 113():269-302. PubMed ID: 24290389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in plasma cytokine levels in chinese children with autism spectrum disorder.
    Hu CC; Xu X; Xiong GL; Xu Q; Zhou BR; Li CY; Qin Q; Liu CX; Li HP; Sun YJ; Yu X
    Autism Res; 2018 Jul; 11(7):989-999. PubMed ID: 29522267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence supporting an altered immune response in ASD.
    Mead J; Ashwood P
    Immunol Lett; 2015 Jan; 163(1):49-55. PubMed ID: 25448709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune related factors in pathogenesis of autism spectrum disorders.
    Szachta P; Skonieczna-Żydecka K; Adler G; Karakua-Juchnowicz H; Madlani H; Ignyś I
    Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3060-72. PubMed ID: 27460736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of IL-17 receptor leads to increased oxidative inflammation in peripheral monocytes of autistic children.
    Nadeem A; Ahmad SF; Attia SM; Bakheet SA; Al-Harbi NO; Al-Ayadhi LY
    Brain Behav Immun; 2018 Jan; 67():335-344. PubMed ID: 28935156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune dysregulation in autism spectrum disorder.
    Noriega DB; Savelkoul HF
    Eur J Pediatr; 2014 Jan; 173(1):33-43. PubMed ID: 24297668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal Cytokine Profiles Associated With Autism Spectrum Disorder.
    Krakowiak P; Goines PE; Tancredi DJ; Ashwood P; Hansen RL; Hertz-Picciotto I; Van de Water J
    Biol Psychiatry; 2017 Mar; 81(5):442-451. PubMed ID: 26392128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin as a Novel Interventional Candidate for Fragile X Syndrome with Autism Spectrum Disorder in Humans.
    Won J; Jin Y; Choi J; Park S; Lee TH; Lee SR; Chang KT; Hong Y
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28632163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuro-Inflammatory Mechanisms in Developmental Disorders Associated with Intellectual Disability and Autism Spectrum Disorder: A Neuro- Immune Perspective.
    Di Marco B; Bonaccorso CM; Aloisi E; D'Antoni S; Catania MV
    CNS Neurol Disord Drug Targets; 2016; 15(4):448-63. PubMed ID: 26996174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between cytokines, endocrine stress response, and gastrointestinal symptoms in autism spectrum disorder.
    Ferguson BJ; Marler S; Altstein LL; Lee EB; Mazurek MO; McLaughlin A; Macklin EA; McDonnell E; Davis DJ; Belenchia AM; Gillespie CH; Peterson CA; Bauman ML; Margolis KG; Veenstra-VanderWeele J; Beversdorf DQ
    Brain Behav Immun; 2016 Nov; 58():57-62. PubMed ID: 27181180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The progress of chemokines and chemokine receptors in autism spectrum disorders.
    Ye J; Wang H; Cui L; Chu S; Chen N
    Brain Res Bull; 2021 Sep; 174():268-280. PubMed ID: 34077795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond the brain: A multi-system inflammatory subtype of autism spectrum disorder.
    Thom RP; Keary CJ; Palumbo ML; Ravichandran CT; Mullett JE; Hazen EP; Neumeyer AM; McDougle CJ
    Psychopharmacology (Berl); 2019 Oct; 236(10):3045-3061. PubMed ID: 31139876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of Neuroinflammation and Encephalitis in Autism.
    Kern JK; Geier DA; Sykes LK; Geier MR
    Front Cell Neurosci; 2015; 9():519. PubMed ID: 26834565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbid epilepsy in autism spectrum disorder: Implications of postnatal inflammation for brain excitability.
    Lewis ML; Kesler M; Candy SA; Rho JM; Pittman QJ
    Epilepsia; 2018 Jul; 59(7):1316-1326. PubMed ID: 29858515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mast cells - Cytokines axis in Autism Spectrum Disorder.
    Kovacheva E; Gevezova M; Maes M; Sarafian V
    Neuropharmacology; 2024 May; 249():109890. PubMed ID: 38431049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA expression changes in association with changes in interleukin-1ß/interleukin10 ratios produced by monocytes in autism spectrum disorders: their association with neuropsychiatric symptoms and comorbid conditions (observational study).
    Jyonouchi H; Geng L; Streck DL; Dermody JJ; Toruner GA
    J Neuroinflammation; 2017 Nov; 14(1):229. PubMed ID: 29178897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.